1.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443
2.
Interpretation of the evidence for the efficacy and safety of statin therapy
by Collins, Rory, Prof
The Lancet (British edition), 2016, Vol.388 (10059), p.2532-2561
3.
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials
by Collins, Rory
The Lancet (British edition), 2001, Vol.357 (9253), p.373-380
4.
Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies
by MacMahon, Stephen
The Lancet (British edition), 2001-02-10, Vol.357 (9254), p.455-462
5.
Major surgery in south India: a retrospective audit of hospital claim data from a large community health insurance programme
by Shaikh, Maaz, MPH
The Lancet (British edition), 2015, Vol.385, p.S23-S23
6.
Blood-pressure-related disease is a global health priority
by MacMahon, Stephen
American journal of hypertension, 2008, Vol.371 (9623), p.1480-1482
7.
Responding to China's hypertensive crisis
by MacMahon, Stephen
The Lancet (British edition), 2009, Vol.374 (9703), p.1728-1729
8.
Differences between blood-pressure-lowering drugs
by MacMahon, Stephen
The Lancet (British edition), 2000, Vol.356 (9227), p.352-353
9.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
by Sundström, Johan
The Lancet (British edition), 2014-08-16, Vol.384 (9943), p.591-598
10.
Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury—outcomes at 6 months
by Edwards, Phil
The Lancet (British edition), 2005, Vol.365 (9475), p.1957-1959
11.
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
by Anthony Rodgers
The Lancet (British edition), 2000, Vol.355 (9212), p.1295-1302
12.
Effect of pravastatin on frequency of fracture in the LIPID study : secondary analysis of a randomised controlled trial
by REID, Ian R
The Lancet (British edition), 2001, Vol.357 (9255), p.509-512
13.
The lowering of blood pressure after stroke
by MacMahon, Stephen
The Lancet (British edition), 2001-12-08, Vol.358 (9297), p.1994-1995
14.
The ADVANCE trial – Authors' reply
by Patel, Anushka
The Lancet (British edition), 2008, Vol.371 (9606), p.26-26
15.
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease
by Katsuya, T
The Lancet (British edition), 1995-06-24, Vol.345 (8965), p.1600-1603
16.
Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
by MacMahon, S
The Lancet (British edition), 1990, Vol.335 (8692), p.765-774
17.
Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context
by Collins, R
The Lancet (British edition), 1990, Vol.335 (8693), p.827-838
18.
The ADVANCE trial/Authors' reply
by Flávio Danni Fuchs
The Lancet (British edition), 2008-01-05, Vol.371 (9606), p.25
19.
Global burden of blood-pressure-related disease, 2001. Commentary
by MACMAHON, Stephen
The Lancet (British edition), 2008, Vol.371 (9623)
20.
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study
by Tonkin, Andrew M
The Lancet (British edition), 2000-12-02, Vol.356 (9245), p.1871-1875
Filter electronic articles 29 Hits
Remove Filters
- Journal Title
- The Lancet
- American Journal Of Hypertension (1)